Patents by Inventor Kyung-Yung Lee

Kyung-Yung Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250066275
    Abstract: The present invention relates to an anthracene derivative compound having a characteristic structure in which an aryl group is introduced into a skeletal structure in which deuterium-substituted phenyl and anthracene are linked. In addition, the present invention relates to a high-efficiency, long-life organic light-emitting device of which the luminous efficiency and lifetime characteristics are significantly improved by employing a polycyclic compound having a characteristic structure as a dopant for a light-emitting layer while employing said compound as a host for the light-emitting layer.
    Type: Application
    Filed: December 14, 2022
    Publication date: February 27, 2025
    Applicant: SFC CO., LTD.
    Inventors: Se-jin LEE, Si-In KIM, Seok-bae PARK, Hee-dae KIM, Yeong-tae CHOI, Kyung-tae KIM, Ji-yung KIM, Seung-soo LEE, Kyeong-hyeon KIM, Tae-gyun LEE, Joon-ho KIM
  • Publication number: 20250063948
    Abstract: The present invention relates to an organic light-emitting diode in which a light-emitting layer comprises a compound represented by [chemical formula A] as a host and comprises a compound represented by [chemical formula 3], [chemical formula 4], [chemical formula 3-1] to [chemical formula 4-3] as a dopant, wherein [chemical formula 3], [chemical formula 4], [chemical formula 3-1] to [chemical formula 4-3] are the same as those described in the detailed description of the invention.
    Type: Application
    Filed: November 25, 2022
    Publication date: February 20, 2025
    Inventors: Kyung-Tae KIM, Se-Jin LEE, Si-In KIM, Seok-Bae PARK, Hee-Dae KIM, Yeong-Tae CHOI, Ji-Yung KIM, Seung-Soo LEE, Kyeong-Hyeon KIM, Tae-Gyun LEE, Joon-Ho KIM
  • Patent number: 6193977
    Abstract: The present invention is directed to a pharmaceutical composition comprising an extract of a mixture of Anemarrhena Rhizoma, a member of the family Liliaceae and, Phellodendron bark, a member of the family Rutaceae that produces analgesic and anti-inflammatory effects, and its preparing method. The present invention is applicable to act on inflammation and pain, for example, chronic gastritis, arthralgia, benign prostate hyperplasia, chronic and recurrent cystitis, cervical disc, degenerative joint arthritis, rheumatoid arthritis, tennis elbow, osteoportotic pain, migraine, diabetic neuropathy pain, right flank pain, etc. The present invention a crude extract suitable for long-period administration with less side effects. Also, the present invention does not lead to dependency or resistance.
    Type: Grant
    Filed: March 14, 2000
    Date of Patent: February 27, 2001
    Assignee: Medvill Co., Ltd.
    Inventors: Young-Bok Han, Eun-Kyung Hong, Young-Shin Chung, Sung-Jin Kim, Kyung-Yung Lee, Young-Lok Shin
  • Patent number: 6113909
    Abstract: The present invention relates to a pharmaceutical composition for the treatment of hepatitis C which comprises a mixed extract, particularly a mixed aqueous extract or a mixed alcohol extract, of Phellodendron amurense RUPRECHT cortex and Patrinia scabiosaefolia FISCH. as an active ingredient. The mixed extract according to the present invention exhibits an anti-viral activity for hepatitis C and help prevents hepatic cirrhosis orginated from hepatitis C, and further treats hepatitis and hepatic cirrhosis by potentiating the immunological function to inhibit the proliferation of hepatitis C virus and stimulating the proliferation of T helper cells to increase the host immune system. Furthermore, the mixed extract of the present invention is a mixed extract of natural plants characterized in that it does not exhibit any side effects nor drug resistance, and its activity is maintained even when used for a long period.
    Type: Grant
    Filed: April 6, 1999
    Date of Patent: September 5, 2000
    Assignees: Young Hee Kim, Young Bok Han
    Inventors: Young Bok Han, Eun Kyung Hong, Young Shin Chung, Bo Im Yoo, Sang Geon Kim, Kyung Yung Lee
  • Patent number: 5891864
    Abstract: The present invention relates to an anti-cancer composition containing acridine derivatives and guanosine compounds. In the composition of the present invention, the acridine derivative and the guanosine compound are present in the weight ratio of 1:0.1-5.0, preferably 1:0.3-3.0 and more preferably 1:0.5-1.5. In the composition of the present invention, most preferably the acridine derivative is acriflavine neutral and the guanosine compound is guanosine hydrate. Although acridine derivatives and guanosine compounds used as an active ingredient in the present composition have substantially no anti-cancer effect when they are used individually, the combination of acriflavine neutral and guanosine hydrate which potentiates the effect of acriflavine neutral, i.e. the composition(AG60) according to the present invention, exhibits reduced toxicity and increased anti-cancer effect in comparison to the use of acriflavine neutral or guanosine hydrate alone.
    Type: Grant
    Filed: November 3, 1995
    Date of Patent: April 6, 1999
    Assignees: Yung Bok Han, Tae Rim Pharm. Co., Ltd.
    Inventors: Yung Bok Han, Hong Ki Kyung, Chun Won Kim, E Tay Ahn, Jong Bae Kim, Hyo Suk Lee, Kyung Yung Lee, Eun Kyung Hong, Hee Sook Choi, Sang Geon Kim, Bo Im Yoo, Hae Kyung Kwon